Performance characteristics of a cystatin C immunoassay with avian antibodies

Upsala Journal of Medical Sciences

Volumn 112, Issue 1, 2007, Pages 21-37

  Sunde, Kathrin ^a   Nilsen, Tom ^a   Flodin, Mats ^b  

^a Gentian AS   (Norway)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYSTATIN; CYSTATIN C;

ANIMAL; ARTICLE; BIRD; HUMAN; IMMUNOASSAY; IMMUNOLOGY; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTIBODIES; BIRDS; CYSTATINS; HUMANS; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

EID: 37349056538     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000-1967-092     Document Type: Article

References (25)

1. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine.Kidney Int 1995;47:312-8.
2. Grubb AO, Löfberg H. Human ∼-trace, a basic microprotein: Amino acid sequence and presence in the adenohypophysis. Proc. Nati. Acad. Sci. USA 1982;79:3024-7.
3. Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, Grubb A. . Structure and expression of the human cystatin C gene. Biochem. J. 1990;268:287-94.
4. Jacobsson B, Lignelid H, Bergerheim US. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology 1995;26:559-64.
5. Grubb AO. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem 2000;35:63-99.
6. Laterza OF, Price CP, Scott MG. Cystatin. C: an improved estimator of glomerular filtration rate? Clin Chem 2002;48:5;63-99.
7. Data from an unpublished patient study carried out at Uppsala University Hospital and Karlstad Hospital in Sweden using Gentian cystatin C immunoassay. March 2006.
8. Larsson A, Malm J, Grubb A, Hansson LO. Calculation of glomerular filtration rate expressed in mL/min from plasma Cystatin C values in mg/L. Scand. J. Lab. Invest. 2004;64, 25-30.
9. Stabuc B, Vrhovec L Stabuc-Silih M, Cizej TE. lmproved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin Chem 2000;46:193-7.
10. Bricon T, Thervet E, Froissart M, Benlakehal M, Bousquet B, Legendre C, et al. Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. Clin Chem 2000;46:1206-7.
11. Harmoinen APT, Kouri TT, Wirta OR, Lehtimki TJ, Rantalaiko V, Turjanmaa VMH, et al. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol 1 999;52:363-70.
12. Schade R, Hlinak A, Marburger A, Henklein P, Morgenstern R, Blankenstein P et al. Advantages of using egg yolk antibodies in the life sciences: the results of five studies. ATLA 1997;25:555-586.
13. Larsson A, Balow RM, Lindahl TL, Forsberg PO. Chicken antibodies: taking advantage of evolution - a review. Poultry Science 1993;72:1807-1812.
14. Carlander D, Larsson A. Avian antibodies can eliminate interference due to complement activation in ELISA.Ups J Med Sci. 2001;106:189-95.
15. NCCLS EP7-A. Interference Testing in Clinical Chemistry; Approved Guideline. Vol 22, No 27.
16. Sonntag O, Scholer A. Drug interference in clinical chemistry: recommendation of drugs and their concentrations to be used in drug interference studies. Ann Clin Biochem 2001;38:376-385.
17. Burtis CA, Ashwood ER, Bruns DE.TIETZ Textbook of CLINICAL CHEMISTRY and MOLECULAR DIAGNOSTICS, fourth edt, Elsevier Saunders.
18. NCCLS EP6-A. Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Ap-proved Guideline. Vol 23, No 16
19. NCCLS EP5-A. Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline Vol 19, No 2
20. NCCLS EP17-A. Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline. Vol 24, No 34
21. NCCLS EP9-A2. Method Comparison and Bias Estimation Using Patient samples; Approved Guideline-Second Edition. Vol 22, No 19
22. NCCLS EP10-A2. Preliminary Evaluation of Quantitative Clinical Laboratory Methods; Approved Guideline-Second edition. Vol 22, No 29
23. European Standard EN 13640. Stability testing of in vitro diagnostic reagents. 2002.
24. NCCLS C28-A. How to define and Determine Reference Intervals in the Clinical Laboratory; Approved Guideline-Second Edition. Vol15,No 4
25. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particleenhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997;43:6:1016-1022.